Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL

YAKHTEH

ISSN 1561-4921 · IRAN · Quarterly · Founded 1999

YAKHTEH: subscription journal; community-reported acceptance: easy.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review time—No reports yet
APC—No source gives fee information
AcceptanceEasyCommunity average
Articles per year—No count yet
Indexed in—No database record yet

Scope

Aims, scope and focus

By OpenAlex counts of its recent articles, YAKHTEH's largest topics are Bone Tissue Engineering Materials, Parkinson's Disease Mechanisms and Treatments and Multiple Sclerosis Research Studies, together about 26.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Bone Tissue Engineering MaterialsEngineering13.3%
  2. Parkinson's Disease Mechanisms and TreatmentsMedicine6.7%
  3. Multiple Sclerosis Research StudiesMedicine6.7%
  4. Mesenchymal stem cell researchMedicine6.7%
  5. Pain Mechanisms and TreatmentsMedicine6.7%
  6. Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology6.7%
  7. Dental Implant Techniques and OutcomesDentistry6.7%
  8. Chronic Kidney Disease and DiabetesMedicine6.7%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

Indexed in: no record yet.

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

h-index
0OpenAlex ·
i10-index
0OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average acceptance (community reports)
EasyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Before you submit

Three checks before submitting to YAKHTEH

  1. 1
    ScopeRecent output centres on Bone Tissue Engineering Materials, Parkinson's Disease Mechanisms and Treatments.
    Check scope
  2. 2
    Article type and formatPrepare text, figures and references as the author guidelines ask.
  3. 3
    English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.

The checks are built from this page's data.

Profile

Publication details and official links

Country or region
IRAN
Frequency
Quarterly
Founded
1999
ISSN
1561-4921

FAQ

Frequently asked questions about YAKHTEH

Is YAKHTEH open access, and what is the APC?

YAKHTEH is a subscription journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .